AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
What is the latest Revenue of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,118 Cr |
| Mar2025 | ₹4,178 Cr |
| Mar2024 | ₹3,655 Cr |
| Mar2023 | ₹3,672 Cr |
| Mar2022 | ₹2,723 Cr |
How is Revenue of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,118 Cr | -1.44 | |
| Mar2025 | ₹4,178 Cr | 14.32 | |
| Mar2024 | ₹3,655 Cr | -0.46 | |
| Mar2023 | ₹3,672 Cr | 34.87 | |
| Mar2022 | ₹2,723 Cr | - | |
Compare Revenue of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹10,770.9 Cr | 5.2% | 12.4% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 5.2% |
12.4% |
21.4% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses